Glaucoma, exfoliation

H7_GLAUCOMA_XFG

glaucoma: Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H40.10 Hospital discharge: ICD-9 — 3651B Hospital discharge: ICD-8 — 37512 Cause of death: ICD-10 — H40.10 Cause of death: ICD-9 — 3651B Cause of death: ICD-8 — 37512 2 out of 7 registries used, show all original rules.	4436
4. Check minimum number of events None	4436
5. Include endpoints None	4436
6. Filter based on genotype QC (FinnGen only)	4436

Control definitions (FinnGen only)

Control exclude: H7_GLAUCOMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: H401
Name in latin: Glaucoma capsulare [primarium/residuale] cum syndromate exfoliationis

NAME	H7_GLAUCOMA_XFG
CONTROL_EXCLUDE	H7_GLAUCOMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H4010
HD_ICD_9	3651B
HD_ICD_8	37512
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H4010
COD_ICD_9	3651B
COD_ICD_8	37512
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Glaucoma, exfoliation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	50095	32712	16908
Only index persons	38107	25566	12541
Unadjusted period prevalence (%)
Whole population	0.78	0.94	0.47
Only index persons	0.79	0.94	0.48
Median age at first event (years)
Whole population	74.18	74.76	73.11
Only index persons	73.97	74.56	72.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4436	2498	1938
Unadjusted period prevalence (%)	0.85	0.85	0.85
Median age at first event (years)	72.48	72.27	72.75

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3958: Matched controls
39578

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S01EE03

ATC

bimatoprost; ophthalmic

88.8

323.0

797

112

H40.9

ICD-10 Finland

Glaucoma, unspecified

190.6

323.0

456

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

4503599627370496.0

323.0

3849

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

3.8

323.0

2715

14465

S01ED01

ATC

timolol; ophthalmic

46.3

323.0

1195

366

XCW99

NOMESCO Finland

Other investigative procedure of eye

6.0

323.0

1153

2518

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

75.0

323.0

393

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

292.6

323.0

1218

S01EC01

ATC

acetazolamide; systemic

67.4

323.0

850

160

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

37.6

323.0

550

169

XCH00

NOMESCO Finland

Eye pressure measurement

13.8

323.0

633

538

S01EX03

ATC

78.7

323.0

903

148

S01EE05

ATC

tafluprost; ophthalmic

61.9

323.0

975

208

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

1265.5

323.0

347

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

323.0

431

S01EC04

ATC

brinzolamide; ophthalmic

142.0

323.0

1526

174

S01EC54

ATC

brinzolamide, combinations; ophthalmic

227.6

323.0

498

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

6.9

323.0

964

1754

XCK00

NOMESCO Finland

Perimetry

33.7

323.0

1521

719

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

637.1

323.0

1411

CHD00

NOMESCO Finland

Laser trabeculoplasty

1478.5

323.0

726

Z96.1

ICD-10 Finland

Presence of intraocular lens

5.9

323.0

1729

4573

114

Kela drug reimbursment

Glaucoma

331.9

323.0

3446

784

S01EE01

ATC

latanoprost; ophthalmic

79.3

323.0

2129

573

S01EC03

ATC

dorzolamide; ophthalmic

109.2

323.0

618

S01EE04

ATC

travoprost; ophthalmic

54.9

323.0

680

149

S01ED51

ATC

timolol, combinations; ophthalmic

140.0

323.0

2801

671

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2418.5

323.0

1167

H40.0

ICD-10 Finland

Glaucoma suspect

318.6

323.0

1291

CHC05

NOMESCO Finland

Iridotomy

94.8

313.3

346

CS494

NOMESCO Finland

Other visual field testing

34.8

308.2

405

129

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

45.2

307.1

381

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.7

291.4

1191

3331

WX140

NOMESCO Finland

Parabulbar anesthesy

9.3

288.1

642

808

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

3.3

278.6

2427

12712

S01ED02

ATC

betaxolol; ophthalmic

56.7

268.2

319

H40.11

ICD-10 Finland

Low pressure glaucoma

154.2

259.3

273

CHD35

NOMESCO Finland

Laser goniopuncture

2494.1

255.8

245

S01EB01

ATC

pilocarpine; ophthalmic

75.8

254.1

289

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

+∞

252.8

240

H25.1

ICD-10 Finland

Senile nuclear cataract

3.2

252.1

2283

11937

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

235.8

224

XCK10

NOMESCO Finland

Photography of fundus of eye

4.7

235.0

915

2367

H40

ICD-10 Finland

Glaucoma

41.8

207.9

262

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

97.5

200.5

221

XCH05

NOMESCO Finland

Eye pressure longterm registration

193.3

194.9

202

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.7

191.3

2288

13295

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

+∞

183.8

175

CHD99

NOMESCO Finland

Other filtering operation

+∞

173.2

165

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

5.7

172.2

537

1056

S01EA03

ATC

apraclonidine; ophthalmic

27.1

170.2

238

S01EA02

ATC

dipivefrine; ophthalmic

221.0

144.9

149

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

81.8

139.4

157

CFW99

NOMESCO Finland

Other operation on conjunctiva

659.2

130.3

128

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.9

128.1

916

3682

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

120.4

115

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

118.3

113

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

+∞

117.2

112

ZXC20

NOMESCO Finland

Use of chemical agents

6.7

100.8

271

431

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

6.2

95.0

269

458

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

9.2

92.7

201

229

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.7

90.8

700

2880

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

+∞

85.7

F93

ICPC

Glaucoma

63.4

85.0

H26.4

ICD-10 Finland

After-cataract

2.4

75.4

735

3409

H34.8

ICD-10 Finland

Other retinal vascular occlusions

5.6

71.3

217

403

H40.1

ICD-10 Finland

Primary open-angle glaucoma

89.6

71.2

3708

FHL

Trabeculectomy or equivalent

+∞

67.9

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

+∞

67.9

ZXA05

NOMESCO Finland

Left side

1.9

67.3

1294

7997

SPAT1009

SPAT

Measurement of intraocular pressure

8.7

67.0

149

177

37512

ICD-8 Finland

Glaucoma, Chronicum capsulare

+∞

66.8

H40.8

ICD-10 Finland

Other glaucoma

337.6

66.7

H25.8

ICD-10 Finland

Other senile cataract

2.1

63.2

837

4445

H04.10

ICD-10 Finland

Dry eye syndrome

2.7

63.0

462

1815

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

16.4

61.9

101

CS2P4

NOMESCO Finland

Optic nerve head imaging

57.1

61.9

H20.1

ICD-10 Finland

Chronic iridocyclitis

14.8

59.0

100

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

56.4

H40.12

ICD-10 Finland

Pigmentary glaucoma

+∞

56.4

3650A

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]

+∞

54.3

H25.0

ICD-10 Finland

Senile incipient cataract

2.7

53.2

411

1657

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

51.6

485

2176

S01BC03

ATC

diclofenac; ophthalmic

4.4

51.4

196

464

H27.1

ICD-10 Finland

Dislocation of lens

14.0

51.3

CHD10

NOMESCO Finland

Trabeculectomy

+∞

51.1

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

6.4

45.9

125

202

S01FA01

ATC

atropine; ophthalmic

11.7

45.8

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

121.4

44.8

ZXA00

NOMESCO Finland

Right side

1.7

44.6

1265

8597

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

14.3

42.6

TCG20

NOMESCO Finland

Laser suture lysis in cornea or sclera

+∞

41.7

XCW10

NOMESCO Finland

Assessment of vision

15.8

40.9

A98

ICPC

Health maint/preventive medicine

1.7

39.4

3281

29123

CFB00

NOMESCO Finland

Suture of conjunctiva

47.5

38.8

H44.5

ICD-10 Finland

Degenerated conditions of globe

72.6

38.0

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.4

36.8

327

1416

CHB99

NOMESCO Finland

Other operation on anterior chamber and anterior chamber angle

131.2

36.7

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

+∞

36.5

H16.0

ICD-10 Finland

Corneal ulcer

3.4

35.8

184

565

H21.0

ICD-10 Finland

Hyphaema

18.6

35.7

37597

ICD-8 Finland

Glaucoma, Suspicio glaucomatis

+∞

35.5

ZXA10

NOMESCO Finland

Bilateral

1.7

35.2

856

5492

S01EX

ATC

Other antiglaucoma preparations

+∞

32.3

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

3.5

32.3

155

451

S01BC05

ATC

ketorolac; ophthalmic

2.3

32.0

303

1350

CHC03

NOMESCO Finland

Laser iridoplasty

+∞

31.3

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

+∞

31.3

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

8.4

31.1

CKD60

NOMESCO Finland

Anterior vitrectomy

5.5

30.7

173

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

17.0

29.7

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

294.0

28.8

WX142

NOMESCO Finland

Sub-tenon anesthesy

11.7

27.6

F43

ICPC

Eye, Other diagnostic procedure

4.6

27.3

211

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

5.2

27.2

169

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

9.4

27.1

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

3.2

26.1

144

467

CWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in eye and adjacent structures

135.8

25.6

H18.1

ICD-10 Finland

Bullous keratopathy

12.6

25.3

F38

ICPC

Eye, Other laboratory test NEC

11.3

25.1

H31.4

ICD-10 Finland

Choroidal detachment

70.3

24.8

WX002

NOMESCO Finland

Sedation and analgesia

1.6

24.7

790

5388

Z3231

NOMESCO Finland

Registered nurse

1.5

24.3

1039

7578

S01EX05

ATC

netarsudil; ophthalmic

+∞

24.0

CA1ME

NOMESCO Finland

Ultrasound oculometry

5.9

23.6

116

H27.8

ICD-10 Finland

Other specified disorders of lens

9.1

22.5

TCG10

NOMESCO Finland

Removal of sutures from cornea

7.3

21.7

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.4

20.1

182

793

CKC12

NOMESCO Finland

Photocoagulation of retina

2.6

19.9

153

611

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

19.5

1517

12290

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

11.4

18.4

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

10.7

18.4

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

20.1

17.7

XCD20

NOMESCO Finland

Photoangiography of eye

2.7

16.9

113

419

CFD10

NOMESCO Finland

Repair of conjunctiva

35.2

16.7

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.6

16.5

213

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.7

16.2

330

1977

SPAT1312

SPAT

General health counselling

1.4

15.9

1018

7917

H35.36

ICD-10 Finland

Macular cyst

5.4

15.8

SPAT1325

SPAT

Vaccination

1.3

15.6

1428

11751

H01.0

ICD-10 Finland

Blepharitis

2.2

15.6

155

712

WX110

NOMESCO Finland

Local anesthesy

1.3

15.1

1961

16950

ZXD20

NOMESCO Finland

Day surgery

1.6

14.5

427

2824

CKC20

NOMESCO Finland

Cryopexy of undetached retina

9.4

14.4

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.2

14.3

146

677

H26.2

ICD-10 Finland

Complicated cataract

3.8

14.2

156

CJG15

NOMESCO Finland

Extraction of dislocated lens with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

30.1

13.9

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.4

13.7

118

507

CHC10

NOMESCO Finland

Peripheral iridectomy

+∞

13.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

13.5

1273

10461

S01FA04

ATC

cyclopentolate; ophthalmic

3.6

13.4

164

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

25.8

13.3

CJF15

NOMESCO Finland

Secondary implantation of skleral fixed artificial lens in posterior chamber

11.5

13.3

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

5.4

13.3

SPAT1301

SPAT

No procedures

1.3

13.2

1192

9730

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.7

13.2

260

1543

SPAT1263

SPAT

Sampling

1.3

13.2

1459

12256

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

14.1

12.7

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

12.6

827

6421

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

12.5

CHB30

NOMESCO Finland

Goniotomy

+∞

12.5

S01EB02

ATC

carbachol; ophthalmic

+∞

12.5

F99

ICPC

Eye/adnexa disease other

4.6

12.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

12.4

1090

8845

J01DB01

ATC

cefalexin; oral

1.3

12.4

2689

24583

S01AD03

ATC

aciclovir; ophthalmic

2.1

12.2

143

707

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

37.6

12.2

Z94.7

ICD-10 Finland

Corneal transplant status

6.7

12.2

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

12.0

454

3175

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

12.0

1343

11266

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

11.7

120

560

N02BE01

ATC

paracetamol; systemic, rectal

1.3

11.5

3120

29207

3656

FHL

Combined cataract glaucoma surgery

+∞

11.5

CGG60

NOMESCO Finland

Reinforcement of sclera using graft

+∞

11.5

H40.29

ICD-10 Finland

Other [primary] glaucoma with closed ventricular angle

+∞

11.5

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.7

11.4

130

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

11.3

1822

15961

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.0

11.2

138

697

F29

ICPC

Eye symptom/complaint other

1.7

11.1

247

1519

CG2T4

NOMESCO Finland

Topography assessment of cornea

4.2

11.1

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

11.0

149

780

CJE15

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

2.9

10.8

229

H54.4

ICD-10 Finland

Blindness, monocular

8.0

10.6

H16.9

ICD-10 Finland

Keratitis, unspecified

3.1

10.5

183

H57.1

ICD-10 Finland

Ocular pain

2.4

10.5

368

3702

FHL

Trabeculotomy

+∞

10.4

H18.2

ICD-10 Finland

Other corneal oedema

7.7

10.4

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

4.4

10.1

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

10.0

1319

11224

H20.8

ICD-10 Finland

Other iridocyclitis

10.0

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.3

9.8

394

H25.2

ICD-10 Finland

Senile cataract, morgagnian type

3.6

9.7

118

CWW99

NOMESCO Finland

Other reoperation on eye and adjacent structures

55.1

9.6

H54.1

ICD-10 Finland

Severe visual impairment, binocular

7.8

9.6

R42

ICD-10 Finland

Dizziness and giddiness

1.3

9.5

893

7265

S01BA09

ATC

clobetasone; ophthalmic

11.4

9.5

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

9.5

792

6343

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

6.0

9.5

H52.1

ICD-10 Finland

Myopia

2.9

9.4

191

SPAT1310

SPAT

Counselling related to known health issue

1.3

9.4

1015

8412

H27.0

ICD-10 Finland

Aphakia

6.6

9.4

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.8

9.4

204

CHC00

NOMESCO Finland

Iridotomy

+∞

9.4

H40.21

ICD-10 Finland

Intermittent glaucoma with closed ventricular angle

+∞

9.4

3652B

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]

+∞

9.4

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.2

9.0

379

S18

ICPC

Laceration/cut

1.2

8.9

1412

12234

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

8.8

991

8244

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

10.7

8.8

H3603, E103

ICD-10 Finland

4.6

8.6

SPAT1153

SPAT

Removal of sutures

1.3

8.5

1085

9159

S01XA18

ATC

ciclosporin; ophthalmic

4.9

8.5

SPAT1053

SPAT

Memory test

1.3

8.5

774

6266

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

8.4

1060

8935

CHD60

NOMESCO Finland

Deep sclerectomy without implant

90.2

8.4

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

90.2

8.4

3703

FHL

Laser operation on ventricular angle under general anesthesia

+∞

8.3

CHD30

NOMESCO Finland

Laser trabeculectomy

+∞

8.3

CFW10

NOMESCO Finland

Conjunctival manipulation with a needle (needling)

+∞

8.3

3656X

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]

+∞

8.3

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

8.3

181

1111

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

8.2

1551

13653

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

8.2

579

4515

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

14.5

8.2

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

8.2

551

4271

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

8.1

792

6465

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.1

8.1

417

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

3.4

8.0

111

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.2

7.8

365

CJF20

NOMESCO Finland

Removal of artificial lens

15.0

7.7

H52.2

ICD-10 Finland

Astigmatism

3.1

7.6

126

S01AX11

ATC

[U] ofloxacin; ophthalmic

1.7

7.6

167

1028

CHB15

NOMESCO Finland

Puncture of anterior chamber of eye with replacement of aqueous

11.8

7.6

CKD40

NOMESCO Finland

Endophotocoagulation of retina

2.8

7.5

162

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

4.8

7.4

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.7

7.4

180

R4110

NOMESCO Finland

Physiotherapy

0.8

7.4

585

7209

3719

FHL

Other measure in this category

+∞

7.3

CHB50

NOMESCO Finland

Trabeculotomy

+∞

7.3

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

7.3

792

6543

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.6

7.2

H13

ICPC

Plugged feeling ear

1.3

7.2

651

5255

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.0

7.1

396

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

2.2

6.9

302

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.9

1311

11502

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

3.7

6.8

CDC00

NOMESCO Finland

Enucleation of eye

16.7

6.7

P20

ICPC

Memory disturbance

1.3

6.7

612

4944

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

6.7

793

6611

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

6.7

139

846

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

22.5

6.7

N06AX11

ATC

mirtazapine; oral

1.2

6.6

981

8382

3661A

ICD-9 Finland

Cataract, Senile cataract

1.9

6.6

498

H52.0

ICD-10 Finland

Hypermetropia

2.6

6.6

170

CJG40

NOMESCO Finland

Extraction of dislocated lens with implantation of artificial scleral fixed lens in posterior chamber and iridectomy or iridotomy

14.3

6.4

Z01.2

ICD-10 Finland

Dental examination

1.2

6.4

942

8044

Z3226

NOMESCO Finland

Physiotherapist

0.8

6.3

386

4922

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

6.3

763

6371

CG2Z4

NOMESCO Finland

Specialised imaging of cornea

8.1

6.3

H44.4

ICD-10 Finland

Hypotony of eye

18.0

6.3

H26.02

ICD-10 Finland

Presenil cataract

2.1

6.3

326

3711

FHL

Cyclodiateria or cryocoagulation

+∞

6.2

37511

ICD-8 Finland

Glaucoma, Chronicum irritativum sive congestivum

+∞

6.2

3656F

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]

+∞

6.2

SPAT1097

SPAT

Recording of ECG

1.3

6.2

542

4351

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.5

6.2

217

1495

F28

ICPC

Limited function/disability (F)

3.2

6.2

G04CA01

ATC

alfuzosin; oral

1.4

6.2

361

2734

R53

ICD-10 Finland

Malaise and fatigue

1.2

6.1

762

6391

H54.5

ICD-10 Finland

Severe visual impairment, monocular

4.4

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000963) Hemoglobin [Mass/volume] in Blood

3830

34183

1.88

44.94

26.5

27.4

g/l

129.9

130.0

0.19

3748

33321

(3035941) MCH [Entitic mass]

3829

34174

1.88

44.89

26.2

27.1

30.5

30.4

3.17

3746

33295

(3024731) MCV [Entitic volume]

3829

34174

1.88

44.89

26.2

27.2

92.1

91.8

2.94

3747

33295

(3026361) Erythrocytes [#/volume] in Blood

3829

34175

1.88

44.87

26.3

27.2

e12/l

4.3

2.56

3681

32721

(3007461) Platelets [#/volume] in Blood

3828

34173

1.88

44.69

26.3

27.2

e9/l

238.2

241.0

1.75

3704

32877

(3010813) Leukocytes [#/volume] in Blood

3829

34185

1.88

44.69

26.3

27.3

e9/l

6.8

7.0

5.35

3682

32724

(3019550) Sodium [Moles/volume] in Serum or Plasma

3782

33723

1.83

43.12

21.6

22.4

mmol/l

139.5

0.08

3676

32646

(3023103) Potassium [Moles/volume] in Serum or Plasma

3785

33769

1.83

42.91

21.8

22.6

mmol/l

4.0

0.04

3671

32635

(40761511) CBC panel - Blood by Automated count

3643

32150

1.75

42.81

17.9

18.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3713

33148

1.74

39.28

11.0

11.3

u/l

22.5

23.3

1.57

3527

31386

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3608

32044

1.68

37.92

17.5

18.6

mg/l

26.0

27.5

1.62

2988

26648

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3478

30788

1.60

34.99

5.5

5.4

mmol/l

2.5

0.05

3079

27203

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3328

29193

1.56

34.51

5.3

5.0

mu/l

2.1

0.16

2921

25759

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3376

29716

1.57

34.41

4.8

4.7

mmol/l

4.4

0.00

2987

26331

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3474

30848

1.58

33.37

5.3

5.2

mmol/l

6.1

0.42

3037

26921

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3335

29377

1.55

32.85

4.8

4.7

mmol/l

1.5

2.00

2923

25817

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3349

29704

1.52

30.23

6.8

6.7

mmol/mol

41.2

41.3

0.17

2968

26527

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3210

28392

1.47

27.84

4.3

4.2

mmol/l

1.2

1.3

5.88

2785

24635

(3013707) Erythrocyte sedimentation rate by Westergren method

2854

24730

1.43

27.32

4.3

mm/h

14.8

15.8

2.55

2569

22335

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1627

12794

1.43

26.85

4.9

5.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3022

26787

1.40

23.06

6.8

7.4

u/l

82.0

82.6

0.17

2805

24779

(3037467) Urinalysis macro (dipstick) panel - Urine

2787

24376

1.39

23.01

5.2

5.1

—

(3035350) Ketones [Presence] in Urine by Test strip

2027

16863

1.37

22.77

4.6

4.5

estimate

0.0

0.00

393

3034

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2759

24201

1.37

21.66

4.3

4.1

pmol/l

15.2

0.27

2396

21213

(3009261) Glucose [Presence] in Urine by Test strip

2039

17115

1.35

21.00

4.7

4.6

estimate

0.0

1.08

391

2985

(3021601) Nitrite [Presence] in Urine by Test strip

2011

16879

1.35

20.56

6.0

6.1

estimate

0.0

0.00

394

2999

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3249

29379

1.40

20.41

17.1

17.9

ml/min/173m2

68.9

68.8

0.10

2662

24284

(3031040) Bacteria [#/volume] in Urine by Automated count

2783

24572

1.36

20.15

5.7

e6/l

2286.6

3010.6

0.14

438

(3002385) Erythrocyte distribution width [Ratio]

2791

24678

1.35

19.87

21.0

22.7

14.0

1.18

2717

23981

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1866

15656

1.33

18.41

4.5

4.4

ng/l

79.1

97.0

0.17

1460

12305

(3029937) Albumin [Presence] in Urine by Test strip

1176

9259

1.37

17.51

5.1

5.0

estimate

0.0

0.69

387

2867

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1342

10823

1.34

16.98

2.3

mg/l

3.2

0.30

1128

9066

(3009542) Hematocrit [Volume Fraction] of Blood

2988

26974

1.33

16.80

19.2

20.4

36.9

37.4

1.16

1560

15639

(3044889) 12 lead EKG panel

2623

23278

1.31

16.51

4.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1308

10552

1.34

16.40

6.0

5.7

ug/l

4.0

5.3

0.75

1143

9242

(3041096) Erythrocytes [Presence] in Urine by Automated

1087

8572

1.35

15.73

4.1

4.3

—

(3019150) Specific gravity of Urine by Refractometry

992

7724

1.37

15.55

5.2

5.1

kg/l

1.0

0.21

192

1291

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1986

17084

1.29

15.33

2.2

pmol/l

95.3

93.1

1.17

986

8547

(3015736) pH of Urine

1601

13436

1.30

14.75

4.2

—

6.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2443

21704

1.28

14.14

4.5

4.6

mmol/l

6.9

0.50

2280

20374

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1106

8916

1.32

13.44

1.8

1.7

pmol/l

26016690.6

13276039.2

0.38

861

7043

(3032080) INR in Blood by Coagulation assay

1917

16707

1.26

12.33

12.1

11.4

inr

1.5

1.4

0.36

561

4277

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

653

4928

1.38

12.15

9.0

—

(3013512) EKG study

1373

11527

1.28

11.99

4.9

4.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1044

8502

1.30

11.49

5.4

4.9

22.3

0.03

561

4611

(3024561) Albumin [Mass/volume] in Serum or Plasma

1951

17138

1.25

11.39

4.1

4.4

g/l

34.4

34.2

0.49

1779

15573

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1586

13614

1.26

11.34

2.7

2.9

ug/l

136.4

150.1

1.45

1402

12122

(3026008) Bacteria identified in Urine by Culture

1645

14249

1.25

10.68

3.7

3.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1224

10256

1.27

10.60

1.6

nmol/l

20.6

20.2

0.35

1022

8576

(3019198) Lymphocytes [#/volume] in Blood

1889

16646

1.23

10.37

5.1

5.4

e9/l

1.7

1.8

1.27

1630

14169

(3013650) Neutrophils [#/volume] in Blood by Automated count

2149

19215

1.23

10.21

7.4

8.2

e9/l

4.2

4.4

2.07

1870

16442

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2228

20026

1.23

9.96

6.0

6.4

mmol/l

1.2

0.21

1825

16639

(3003338) MCHC [Mass/volume]

2696

24715

1.23

9.96

24.2

25.0

g/l

330.4

330.0

1.07

2662

24336

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1321

11251

1.25

9.78

2.5

u/l

60.7

59.0

0.48

1216

10206

(40760892) CBC W Ordered Manual Differential panel - Blood

764

6101

1.30

9.55

4.2

4.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1139

9572

1.26

9.42

1.9

1.8

nmol/l

1195.8

1158.7

0.67

839

6951

(3013115) Eosinophils [#/volume] in Blood

1901

16877

1.22

9.39

5.0

5.4

e9/l

0.2

0.42

1631

14345

(3006315) Basophils [#/volume] in Blood

1848

16373

1.22

9.28

4.9

5.3

e9/l

0.0

0.55

1579

13731

(3007853) Bacteria identified in Skin by Aerobe culture

548

4198

1.35

9.15

1.7

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

375

2699

1.43

9.13

5.2

6.1

mmol/l

24.4

24.6

0.41

350

2526

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1671

14697

1.22

8.92

2.3

2.2

nmol/l

80.4

80.7

0.16

1449

12516

(3001604) Monocytes [#/volume] in Blood

1833

16271

1.22

8.91

4.9

5.2

e9/l

0.6

0.43

1568

13617

(3015377) Calcium [Moles/volume] in Serum or Plasma

1551

13561

1.22

8.73

3.1

3.2

mmol/l

2.3

2.4

4.64

1314

11291

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1989

17852

1.21

8.48

2.9

3.1

u/l

49.2

56.1

2.66

1768

15872

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1583

14022

1.20

7.48

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2081

18898

1.19

7.43

5.3

5.8

umol/l

12.5

12.3

0.22

1947

17772

(3007930) Methemoglobin/Hemoglobin.total in Blood

254

1773

1.46

7.32

4.6

4.4

0.9

0.93

237

1671

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1365

11957

1.20

7.21

2.1

u/l

186.0

211.8

0.62

1260

11033

(3047181) Lactate [Moles/volume] in Blood

185

1221

1.54

7.02

4.9

5.5

mmol/l

1.3

1.4

0.32

168

1087

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

254

1798

1.44

6.82

4.6

4.4

1.6

0.29

238

1693

(1761868) Lipid panel - Serum or Plasma

885

7466

1.23

6.78

3.4

3.5

—

(3018010) Neutrophils/100 leukocytes in Blood

1722

15478

1.18

6.69

5.2

5.5

59.4

59.3

0.16

1567

14158

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1985

18069

1.18

6.60

5.2

5.7

mmol/l

1.2

1.18

1750

16029

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1578

14096

1.19

6.56

3.1

3.3

ng/l

1947.9

2069.5

0.41

1341

12243

(3020682) Albumin/Creatinine [Ratio] in Urine

1338

11790

1.19

6.49

3.9

3.8

mg/mmol

8.9

9.4

0.09

863

7229

(3018572) Chloride [Moles/volume] in Blood

139

876

1.61

6.47

5.4

6.0

mmol/l

105.0

104.9

0.02

125

785

(3039000) Anion gap in Blood

139

876

1.61

6.47

5.4

6.0

mmol/l

11.0

11.2

0.29

125

785

(3025159) Blasts/100 leukocytes in Blood

332

2487

1.36

6.41

3.6

3.8

0.0

0.3

1.29

681

(3019060) Gas panel - Arterial blood

375

2866

1.34

6.35

3.8

4.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

1743

15753

1.18

6.20

5.4

5.8

25.2

25.3

0.21

1588

14311

(3017181) Myelocytes/100 leukocytes in Blood

370

2839

1.33

6.10

3.5

3.8

0.9

1.0

0.12

893

(3019069) Monocytes/100 leukocytes in Blood

1716

15507

1.17

6.08

5.4

5.9

9.0

0.41

1567

14199

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

427

3350

1.30

6.01

3.3

3.6

mmol/l

1.2

1.80

369

2856

(3006504) Eosinophils/100 leukocytes in Blood

1707

15430

1.17

6.01

5.2

5.6

2.9

2.8

1.84

1554

14099

(42870588) Differential panel, method unspecified - Blood

1318

11668

1.18

5.96

4.8

5.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

352

2691

1.33

5.96

3.5

3.8

0.1

0.32

823

(3022096) Basophils/100 leukocytes in Blood

1664

15025

1.17

5.91

5.2

5.6

0.6

0.05

1517

13743

(3012516) Albumin [Mass/volume] in Urine

1257

11123

1.18

5.66

3.2

3.1

mg/l

381.9

334.2

0.14

811

6897

(3002179) Metamyelocytes/100 leukocytes in Blood

333

2548

1.33

5.61

3.4

3.7

0.5

0.6

0.80

614

(40768804) Tissue Pathology biopsy report

1457

13111

1.17

5.25

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

499

4067

1.26

5.18

3.4

3.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

223

2.07

5.12

1.1

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

1258

11212

1.17

5.10

3.3

3.0

mmol/l

6.6

0.10

1048

9081

(3021589) Normoblasts [#/volume] in Blood

1549

14071

1.15

4.83

10.4

e9/l

0.0

0.09

1311

11261

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

238

1.98

4.68

1.9

1.8

pmol/l

189.3

204.9

0.38

221

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.76

4.60

1.0

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

398

3214

1.26

4.49

1.6

—

(40761536) Microorganisms panel - Urine sediment

358

2858

1.27

4.44

4.5

4.8

—

(40761535) Cells panel - Urine sediment

411

3345

1.25

4.34

3.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

897

7873

1.17

4.32

1.6

mmol/l

1.2

1.3

1.23

718

6478

(3019832) Treponema pallidum Ab [Presence] in Serum

101

657

1.55

4.24

1.1

1.3

—

(3025941) Bacteria identified in Stool by Culture

220

1660

1.34

4.15

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

664

5705

1.19

4.10

1.2

u/ml

0.7

1.5

6.43

174

1355

(3022145) Colonoscopy Study observation

417

3423

1.24

4.09

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.71

4.08

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

165

1193

1.40

4.07

1.8

1.7

u/l

40.2

38.7

0.44

135

1006

(3048689) Calprotectin [Mass/mass] in Stool

363

2951

1.25

3.89

2.2

1.8

ug/g

131.2

163.1

0.96

279

2230

(3011397) Hemoglobin [Presence] in Urine by Test strip

945

8392

1.16

3.88

4.9

4.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

288

2281

1.28

3.84

2.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

242

1.87

3.82

1.1

—

(3023368) Bacteria identified in Blood by Culture

1316

11979

1.14

3.79

3.8

4.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

134

2.17

3.72

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1721

16024

1.12

3.34

3.9

4.3

—

(3026782) Osmolality of Urine

910

8146

1.15

3.31

2.8

3.0

mosm/kgh2o

525.1

537.8

1.13

769

6889

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

395

1.60

3.18

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

281

2284

1.25

3.07

4.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

177

1359

1.31

3.05

4.8

5.1

—

(3008037) Lactate [Moles/volume] in Venous blood

151

1133

1.34

3.05

3.9

3.5

mmol/l

1.5

1.7

1.90

144

1114

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

121

2.07

2.92

1.0

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

451

3863

1.19

2.91

5.0

6.4

g/l

120.7

118.5

1.72

432

3727

(3016502) Oxygen saturation in Arterial blood

496

4291

1.18

2.85

4.7

6.0

95.5

95.2

0.68

470

4109

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

672

5952

1.15

2.84

3.5

3.3

ug/l

0.8

0.9

1.63

503

4333

(3043409) Potassium [Moles/volume] in Arterial blood

170

1316

1.30

2.79

3.1

3.7

mmol/l

3.8

3.9

0.88

157

1214

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

322

2686

1.21

2.78

2.5

2.9

ml/min/173m2

56.3

57.5

0.25

132

1268

(3051593) INR in Capillary blood by Coagulation assay

262

1.69

2.75

8.4

14.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1041

9518

1.12

2.68

3.2

3.0

u/l

37.8

35.4

0.22

961

8906

(3005322) IgE [Units/volume] in Serum or Plasma

168

1308

1.30

2.66

1.2

u/ml

222.4

207.2

0.06

155

1176

(3038515) Glucose [Moles/volume] in Venous blood

143

1089

1.32

2.65

4.1

3.5

mmol/l

7.7

7.9

0.18

137

1070

(3023420) DNA double strand Ab [Units/volume] in Serum

265

0.38

2.64

1.0

1.2

—

27.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

907

8240

1.13

2.60

3.0

3.1

mmol/l

2.5

5.91

801

7049

(3022948) Iron [Moles/volume] in Serum or Plasma

721

6458

1.14

2.59

2.2

2.4

umol/l

11.3

11.6

0.42

653

5845

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

311

2608

1.21

2.56

1.4

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

811

0.65

2.56

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

255

2098

1.23

2.54

3.0

3.3

e9/l

4.3

0.04

174

1401

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

152

1177

1.30

2.52

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

815

8980

0.89

2.50

3.5

3.8

84.9

83.2

1.15

792

8747

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.47

2.48

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.17

2.40

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

101

746

1.36

2.33

1.9

1.7

mg/l

10.2

12.9

1.92

677

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

467

4095

1.16

2.29

2.4

2.5

ug/l

4.4

6.3

5.31

375

3358

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

173

2149

0.80

2.27

5.8

7.2

mmol/l

24.5

24.4

0.23

157

1969

(3037522) Nuclear Ab [Titer] in Serum

400

3469

1.17

2.27

1.3

titre

500.0

543.5

0.22

807

(3022621) pH of Urine by Test strip

314

2669

1.19

2.26

4.3

3.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

104

777

1.35

2.25

1.7

1.6

—

(3003396) Base excess in Arterial blood by calculation

543

4820

1.14

2.24

4.6

5.8

mmol/l

1.3

1.2

0.30

395

3709

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

1.0

—

(3000991) Gas panel - Venous blood

292

3432

0.84

2.20

5.2

6.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1315

0.75

2.20

4.0

3.5

—

(3006270) Folate [Moles/volume] in Blood

401

1.48

2.18

1.4

1.2

nmol/l

323.5

309.8

0.17

306

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

173

1.74

2.16

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

792

7217

1.12

2.15

1.5

1.7

mg/l

1.7

1.6

0.23

632

5629

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

101

1.98

2.15

1.0

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

101

1.98

2.15

1.9

1.5

nmol/l

0.2

0.14

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

267

1.58

2.11

1.5

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

801

7315

1.12

2.09

1.9

—

(3018418) pH of Serum or Plasma

1274

11913

1.10

2.08

3.6

3.8

7.4

0.91

265

2129

(3024263) Appearance of Synovial fluid

208

0.43

2.06

1.6

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

567

1.38

2.03

1.5

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

475

1.42

2.01

1.5

1.4

—

(3008898) HLA-B27 [Presence]

492

1.41

2.01

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

320

2757

1.17

2.00

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

980

9066

1.10

2.00

2.6

2.8

umol/l

6390.9

7898.0

0.39

813

7480

(3017446) Testosterone [Moles/volume] in Serum or Plasma

181

1480

1.23

1.98

2.6

2.0

nmol/l

11.2

11.1

0.03

157

1241

(3030981) Hyaline casts [#/volume] in Urine by Automated count

256

2172

1.19

1.92

3.0

2.9

e6/l

0.3

0.4

0.40

249

2131

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.05

1.90

1.6

1.4

ng/l

80.9

123.2

1.85

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

199

1653

1.21

1.88

2.9

3.0

pmol/l

4.4

4.3

0.74

174

1388

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

143

1.75

1.88

1.8

e9/l

0.2

0.37

127

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.98

1.84

1.2

1.1

ratio

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

408

3605

1.14

1.84

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

253

1.55

1.83

1.2

miu/ml

65.4

218.8

—

(3018095) Leukocytes [#/volume] in Urine

1426

13469

1.09

1.83

4.0

4.1

e6/l

131.7

140.1

0.09

1081

9796

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

296

2563

1.17

1.77

1.5

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

696

1.31

1.75

2.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

243

2077

1.18

1.71

6.3

7.9

—

(3003694) ABO and Rh group [Type] in Blood

805

7433

1.10

1.71

1.3

—

(3044941) Cell count panel - Synovial fluid

610

0.69

1.67

1.2

1.4

—

(3042936) Bacteria identified in Isolate by Culture

574

5214

1.12

1.67

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

130

1049

1.25

1.65

1.5

1.4

ug/g

238.3

273.4

1.57

640

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.80

1.65

1.1

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

205

1734

1.19

1.64

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

910

8468

1.09

1.64

2.7

2.8

e6/l

6.2

5.4

0.84

797

7406

(3010838) Calcium [Moles/time] in 24 hour Urine

181

1.61

1.63

1.6

1.7

—

7.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

135

1.71

1.62

1.2

—

(4062490)

213

1.55

1.61

1.4

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

532

1.34

1.59

2.1

2.0

32.0

32.5

0.34

526

(3027801) Oxygen [Partial pressure] in Arterial blood

532

4826

1.12

1.59

4.7

5.8

kpa

11.7

11.8

0.13

503

4542

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1061

0.77

1.59

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1061

0.77

1.59

1.4

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

532

4827

1.12

1.59

4.7

5.8

kpa

5.1

0.11

502

4549

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

152

1.65

1.56

1.8

e6/l

464.5

501.5

0.13

129

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

114

1.76

1.56

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

220

1884

1.18

1.54

1.8

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

502

4549

1.12

1.54

5.0

4.8

34.0

0.01

320

2823

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

784

0.74

1.54

1.5

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

208

1.54

1.53

1.3

g/l

6.5

6.9

0.33

151

(3024139) IgG subclass 3 [Mass/volume] in Serum

208

1.54

1.53

1.3

g/l

0.4

0.5

1.14

152

(3028192) IgG subclass 2 [Mass/volume] in Serum

208

1.54

1.53

1.3

g/l

3.2

2.7

0.58

152

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

714

0.72

1.53

1.8

2.3

201.5

211.6

0.34

672

(3023520) Reticulocytes [#/volume] in Blood

443

3988

1.12

1.52

2.4

e9/l

69.7

67.8

0.44

370

3013

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

286

3258

0.87

1.52

2.4

2.3

u/l

42.2

36.4

0.32

239

2748

(3000475) Leukocytes [#/volume] in Synovial fluid

929

0.76

1.51

1.3

1.6

e6/l

13075.2

17618.7

0.56

649

(3001729) Color of Synovial fluid

0.00

1.49

0.0

1.3

—

(3011648) Oxygen content in Venous blood

256

0.55

1.48

1.6

1.5

9.0

10.3

0.50

256

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

574

1.31

1.48

2.3

2.2

mg/l

37.4

26.0

0.52

137

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

506

4601

1.11

1.47

1.3

iu/ml

35.0

40.6

0.36

166

1408

(3004789) Transferrin [Mass/volume] in Serum or Plasma

649

5988

1.10

1.41

2.1

2.4

g/l

2.3

0.22

590

5427

(3016330) Potassium [Moles/time] in 24 hour Urine

2.42

1.39

1.0

1.2

—

(3019225) pH of Specimen

470

4271

1.11

1.39

4.6

4.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

103

829

1.25

1.39

1.4

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

184

1569

1.18

1.38

1.3

au/ml

65.2

57.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

137

1642

0.83

1.38

2.2

2.6

u/ml

0.4

0.54

950

(3003181) Sodium [Moles/volume] in Urine

105

848

1.24

1.37

1.2

1.3

mmol/l

58.9

60.2

0.14

668

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

166

1954

0.84

1.37

2.7

3.3

mmol/l

23.6

24.2

1.81

150

1740

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.61

1.36

1.3

1.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

1.33

0.0

1.4

—

0.7

—

(3024928) Oxygen saturation in Venous blood

809

0.76

1.33

2.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

1.32

0.0

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

324

3619

0.89

1.31

4.2

5.3

mmol/l

1.4

0.32

306

3465

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.35

1.29

1.6

1.4

—

(3021788) Differential panel - Synovial fluid

680

0.75

1.28

1.4

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

396

1.34

1.27

1.7

u/ml

22.0

25.2

0.16

(3011412) CD3 cells [#/volume] in Blood

235

1.45

1.26

1.9

e9/l

0.8

1.0

1.07

145

(3027273) Bicarbonate [Moles/volume] in Venous blood

259

2290

1.14

1.23

3.8

3.2

mmol/l

24.9

25.2

0.53

252

2233

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.63

1.21

1.0

1.1

—

(4010399)

266

2360

1.14

1.21

1.5

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

162

1386

1.18

1.21

3.0

2.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

306

1.38

1.19

2.3

1.3

u/l

15.9

12.5

0.56

243

(40768441) Liver Pathology biopsy report

186

0.54

1.17

1.0

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

1248

11912

1.07

1.15

3.5

e6/l

130.4

89.3

0.36

1018

9237

(21494755) Public health laboratory ask at order entry panel

508

0.73

1.15

1.3

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

1.15

0.0

1.0

—

(36660697) Celiac disease serology panel - Serum

229

2020

1.14

1.15

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

174

1.50

1.15

1.0

1.1

nmol/l

0.2

13.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

553

0.74

1.14

1.1

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

297

2665

1.12

1.14

3.4

3.0

g/l

126.2

125.9

0.08

285

2604

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

222

0.58

1.13

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

222

0.58

1.13

1.6

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

528

1.27

1.12

2.8

4.1

iu/ml

263.2

3670.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

211

1856

1.14

1.11

1.8

ug/l

1.4

2.3

0.99

171

1564

(4268621)

208

0.58

1.11

3.3

2.2

—

(36304419) Bacteria [Presence] in Urine

1092

10392

1.07

1.10

3.3

3.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

399

0.70

1.09

2.1

2.0

u/ml

214.3

794.7

0.41

388

(3004451) EKG impression Narrative

210

1.43

1.08

1.4

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

547

0.75

1.07

1.1

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

315

2851

1.11

1.05

1.9

2.0

nmol/l

380.7

382.5

0.04

272

2535

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

641

1.24

1.05

3.1

2.8

—

(3026470) Cobalt [Mass/volume] in Blood

279

1.36

1.05

1.9

2.0

ug/l

6.5

3.4

0.49

244

(1002224) Polysomnography panel

510

0.74

1.04

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

162

1.48

1.03

1.1

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

1136

10853

1.06

1.01

3.3

3.5

e6/l

0.4

0.6

1.02

910

8308

(3034988) Calcium [Moles/volume] in Capillary blood

1.69

1.01

1.5

1.7

mmol/l

1.2

0.05

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

604

5648

1.08

1.01

2.2

2.5

20.2

20.6

0.26

488

4710

(3006184) Hemoglobin [Mass/volume] in Capillary blood

116

984

1.18

1.00

2.1

2.2

g/l

125.1

125.6

0.08

709

(3043410) Blood group antigens tested for on Red Blood Cells

1.62

0.99

1.3

2.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

646

6062

1.08

0.98

1.6

1.9

29.9

30.1

0.26

616

5847

(3006245) CD3-CD19+ cells/100 cells in Blood

1.71

0.98

1.8

1.7

8.5

9.8

0.22

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.71

0.98

1.8

1.6

33.2

28.3

0.51

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

355

0.70

0.98

1.3

1.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.97

0.0

1.1

—

36.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

540

1.24

0.97

1.2

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

124

1.53

0.96

1.4

1.7

u/l

14.0

2146.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

116

1.55

0.96

1.4

19.5

23.1

0.33

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

108

1.58

0.96

2.2

1.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

465

4312

1.09

0.96

3.7

3.1

ng/l

250.4

261.5

0.17

428

3941

(44813793)

141

1.49

0.94

1.1

—

(3045414) Leukocytes [Presence] in Urine

175

1541

1.14

0.94

2.5

2.0

—

(40768797) Stomach Pathology biopsy report

486

4521

1.08

0.93

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.22

0.93

1.2

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

855

8121

1.07

0.92

4.3

ng/l

299.5

435.7

0.49

746

7154

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.73

0.92

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

118

1.53

0.90

2.6

3.0

umol/l

26.3

29.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

195

0.61

0.90

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

102

1.57

0.90

1.1

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

101

0.49

0.89

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

473

0.76

0.89

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.69

0.88

1.8

2.0

—

(4281824)

393

0.74

0.88

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

177

1.41

0.88

1.4

1.6

57.6

67.5

0.84

143

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.86

0.87

1.6

1.4

umol/l

51.0

49.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

805

1.18

0.86

2.2

2.4

mg/l

1.9

1.8

0.72

696

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

161

1.43

0.86

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

299

0.70

0.86

1.7

1.2

u/ml

4.8

—

148

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

112

1.52

0.84

1.4

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.78

0.84

1.5

1.1

—

(3025577) Chromium [Mass/volume] in Blood

274

1.32

0.83

2.2

2.0

ug/l

3.3

2.0

0.85

231

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

597

1.21

0.83

1.2

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

114

0.53

0.82

1.2

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

534

1.22

0.82

5.6

8.0

mmol/l

7.3

7.5

0.22

432

(4094501)

753

0.82

0.81

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

302

1.29

0.81

1.0

1.1

—

19.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

375

0.74

0.81

1.2

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

565

5322

1.07

0.80

2.2

2.3

1.8

0.08

486

4587

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

176

0.62

0.79

1.4

1.1

—

(3049717) Cytology report of Urine Cyto stain

192

1724

1.12

0.79

2.9

2.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

181

1.38

0.79

1.8

15.8

16.3

0.06

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.79

0.0

1.3

—

3634.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.79

0.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.79

0.0

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.79

0.0

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.79

0.0

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

1.7

—

(3023419) Bacteria identified in Sputum by Culture

492

1.22

0.78

1.7

2.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.59

0.78

1.4

1.7

mmol/l

1.2

0.29

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

124

0.56

0.77

2.6

2.0

u/l

9.9

61.3

—

116

(3008757) Leukocyte morphology finding [Identifier] in Blood

462

0.78

0.77

3.6

4.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

109

945

1.16

0.77

1.8

2.3

ug/min

65.5

73.2

0.13

527

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

100

0.50

0.77

1.0

2.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.76

0.0

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

348

0.75

0.76

1.2

1.1

u/ml

307.8

314.1

0.05

199

(3004616) Nuclear Ab [Presence] in Serum

359

1.26

0.75

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

336

0.74

0.75

1.3

1.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

192

1.36

0.74

1.8

38.3

43.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.60

0.74

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.08

0.74

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.08

0.74

1.4

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.08

0.74

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.08

0.74

1.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

496

1.21

0.73

1.2

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

765

0.83

0.73

1.7

2.0

87.4

88.2

0.12

728

(3016038) Potassium [Moles/volume] in Urine

298

1.28

0.73

1.0

1.1

mmol/l

33.8

34.0

0.02

237

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.64

0.73

2.3

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.61

0.72

2.3

2.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

159

1.39

0.72

1.8

2.0

e6/l

650.5

563.5

0.24

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

480

1.21

0.71

1.2

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

526

1.20

0.71

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

363

1.24

0.70

1.6

1.5

g/l

0.8

0.10

278

(21494434) Karyotype in Bone marrow

354

0.76

0.70

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

815

1.16

0.69

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

806

1.16

0.68

1.4

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

239

0.71

0.68

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

239

0.71

0.68

1.5

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

446

1.21

0.68

1.4

63.5

63.0

0.04

283

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

204

0.69

0.68

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.53

0.68

1.0

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

187

1.34

0.68

1.8

69.0

71.0

0.28

171

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

401

1.22

0.67

3.0

4.0

u/ml

71.6

46.3

0.28

391

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

686

1.17

0.67

1.2

u/ml

26.3

4.1

0.48

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

102

1.47

0.67

1.1

1.3

33.4

32.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.63

0.66

1.0

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.63

0.66

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.49

0.66

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

249

0.72

0.66

2.3

2.7

—

(40767503) Oxygen content in Capillary blood by calculation

102

893

1.15

0.66

2.5

16.3

15.6

1.13

464

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.79

0.66

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

1.57

0.65

1.1

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

137

1.39

0.64

1.7

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

137

1.39

0.64

1.7

2.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

377

1.22

0.63

1.2

1.3

nmol/l

—

(3020630) Protein [Mass/volume] in Serum or Plasma

395

3712

1.07

0.63

2.5

2.4

g/l

66.2

65.8

0.52

342

3243

(3020891) Body temperature

188

1714

1.10

0.63

3.9

4.2

—

(40765096) Chromosome analysis panel by Banding

104

0.58

0.61

1.8

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.67

0.61

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

360

3378

1.07

0.61

3.1

3.3

ng/l

93.4

95.5

0.13

297

2762

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.60

0.61

1.5

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

527

1.18

0.60

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.60

0.0

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.60

0.0

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

479

4542

1.06

0.59

3.7

ug/l

34.1

26.8

0.13

408

3740

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

695

1.15

0.59

1.2

u/ml

3.8

5.5

0.51

119

(3022217) INR in Platelet poor plasma by Coagulation assay

689

6600

1.05

0.59

30.7

31.7

inr

1.5

0.35

101

885

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.59

0.0

1.6

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.1

—

5.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

2.2

—

(4211845)

209

0.72

0.59

4.0

3.9

—

(4146454)

445

1.19

0.59

2.8

2.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

157

1.34

0.59

6.4

5.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

541

0.83

0.58

1.4

1.6

mg/l

1.8

3.7

1.23

433

(40768443) Skin Pathology biopsy report

173

1579

1.10

0.58

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

519

4938

1.06

0.58

1.4

1.5

g/l

2.6

2.7

0.56

296

2643

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

464

0.82

0.58

3.4

3.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

113

0.62

0.58

2.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.48

0.57

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

241

0.75

0.56

3.6

3.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

176

1.31

0.56

1.9

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

402

1.20

0.56

4.0

3.8

umol/l

331.6

340.6

0.16

331

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

616

1.15

0.55

3.6

3.3

56.3

59.8

1.07

616

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

307

0.78

0.55

1.6

1.2

u/ml

4.0

4.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

133

1.35

0.54

1.3

1.5

22.4

18.5

0.24

121

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

532

5077

1.05

0.54

1.9

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

205

0.73

0.54

1.7

2.2

ug/min

93.4

61.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

154

1405

1.10

0.53

1.1

1.2

iu/ml

134.0

122.5

0.12

468

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

1.24

0.53

1.2

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.49

0.53

1.4

1.3

—

212.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.49

0.53

1.2

1.4

—

(3018133) Calcium [Moles/volume] in Urine

1.54

0.53

2.3

1.6

mmol/l

1.3

3.2

—

(3020650) Glucose [Presence] in Urine

1.45

0.53

1.3

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

534

0.84

0.52

1.3

1.4

—

(4035726)

294

3130

0.93

0.52

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

260

0.77

0.52

1.4

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

529

5054

1.05

0.52

1.9

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

341

1.20

0.52

1.4

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

107

1191

0.90

0.52

2.6

2.3

g/l

0.0

0.00

1073

(3044007) Cell count panel - Peritoneal fluid

0.62

0.52

1.2

1.7

—

(3010503) CD19 cells [#/volume] in Blood

161

1.31

0.51

1.9

2.0

e9/l

0.1

0.3

0.58

153

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.39

0.50

1.2

2.4

217.4

210.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

372

3923

0.94

0.50

2.4

2.5

umol/l

10.5

10.2

0.07

315

3380

(3037556) Urate [Mass/volume] in Serum or Plasma

118

1.36

0.50

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

334

1.20

0.49

3.0

2.9

mg/l

18.2

29.1

0.58

249

(3019977) pH of Arterial blood

261

1.23

0.49

1.9

2.4

7.4

0.79

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

125

1135

1.10

0.49

1.7

1.6

titre

184.0

241.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

642

1.14

0.49

1.4

1.7

iu/l

2.2

4.2

4.85

184

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

890

0.89

0.48

1.4

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.52

0.48

1.1

1.6

—

(3014891) Appearance of Pleural fluid

1.45

0.48

1.9

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

102

1.37

0.47

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

401

1.17

0.47

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate

1.47

0.47

1.2

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.46

0.46

1.1

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

155

1.29

0.46

1.3

1.5

5.1

3.1

0.36

127

(3015171) Extractable nuclear Ab [Units/volume] in Serum

113

1025

1.10

0.46

1.2

u/ml

0.7

0.9

0.08

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

191

1.26

0.46

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

589

1.14

0.46

1.2

u/ml

2.2

7.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

407

0.83

0.45

2.1

1.6

—

(40757373) Influenza virus identified in Isolate

119

0.67

0.45

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

310

1.19

0.45

1.3

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.59

0.45

1.0

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

206

2205

0.93

0.45

1.8

1.6

g/l

1.5

0.20

175

1854

(3006462) Nitrate [Presence] in Urine

197

0.76

0.44

4.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

0.74

0.43

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

128

0.70

0.43

1.3

1.1

—

(3048879) Bone marrow aspiration report

140

0.71

0.43

1.0

1.4

—

(3045716) Anion gap in Serum or Plasma

193

1.24

0.43

1.9

1.7

mmol/l

8.7

9.4

0.43

155

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

129

0.70

0.43

1.2

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

130

0.69

0.43

7.1

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

131

0.69

0.43

1.0

1.1

—

10.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

116

1060

1.10

0.42

1.2

1.1

titre

—

206.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

537

1.14

0.42

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.56

0.42

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

160

1484

1.08

0.42

2.9

u/ml

16707.4

2015.8

0.44

138

1234

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

111

1214

0.91

0.41

2.6

2.3

g/l

0.0

0.00

100

1078

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

184.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.41

0.0

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.1

—

0.0

—

(3022313) Gas panel - Capillary blood

174

1865

0.93

0.41

3.8

3.9

—

(3005570) Glucose [Moles/volume] in Urine

454

1.15

0.41

2.3

2.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

330

3141

1.05

0.40

2.2

2.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.40

0.0

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1003

0.91

0.40

1.2

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

872

1.10

0.40

3.3

2.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

464

1.14

0.40

1.3

u/l

1096.2

307.8

0.71

436

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.33

0.40

1.1

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

141

1.28

0.40

1.1

1.2

umol/l

14.9

14.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1.31

0.39

1.0

2.6

mu/l

18.1

17.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

537

5177

1.04

0.39

4.2

4.8

mmol/l

1.1

1.0

0.72

487

4680

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.4

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

588

1.12

0.39

1.2

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

215

2025

1.06

0.38

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.36

0.38

1.0

—

(4034850)

119

1096

1.09

0.38

12.4

12.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

157

1463

1.08

0.38

1.8

2.1

ug/l

1682.6

562.1

0.42

145

1374

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

790

1.10

0.37

1.5

iu/ml

55.8

5.0

0.44

200

(40768806) Pleura Pathology biopsy report

536

0.88

0.37

1.5

1.6

—

(3036489) Thrombin time

1070

0.91

0.37

1.5

1.8

21.4

21.8

0.42

982

(3033799) Differential panel - Peritoneal fluid

113

0.71

0.37

1.5

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.35

0.37

1.0

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.30

0.37

7.6

7.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

132

1422

0.93

0.37

3.5

3.3

nmol/l

0.8

0.19

101

1078

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

318

1.16

0.36

1.4

titre

74.0

47.3

—

(3012441) Differential panel - Pleural fluid

544

0.88

0.35

1.4

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.43

0.35

12.3

15.9

mmol/l

3.4

5.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.40

0.35

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

404

1.14

0.35

2.0

2.4

u/field

3.4

1.9

0.25

123

(3045424) Erythrocytes [Presence] in Urine

537

1.12

0.34

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

574

0.89

0.34

1.4

e6/l

105638.4

57022.5

0.38

342

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.36

0.34

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.34

0.34

2.6

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.33

0.33

4.7

8.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

445

0.88

0.32

3.0

3.8

62.7

58.4

0.50

276

(3027008) Opiates [Presence] in Urine

132

0.76

0.32

6.5

1.2

—

(3028300) Cannabinoids [Presence] in Urine

132

0.76

0.32

6.5

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

370

1.14

0.31

1.2

1.3

pmol/l

285.3

259.2

0.16

274

(3020779) Urea [Moles/volume] in Serum or Plasma

346

3595

0.96

0.31

5.5

5.8

mmol/l

11.9

11.7

0.19

323

3352

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.32

0.30

5.7

8.3

—

(3044290) Cell count panel - Cerebral spinal fluid

516

0.89

0.30

1.4

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

428

1.12

0.30

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.29

0.30

1.8

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

650

0.91

0.29

1.4

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

106

987

1.08

0.29

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

130

1.23

0.28

3.1

2.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

459

1.11

0.28

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

332

3199

1.04

0.28

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

298

2865

1.04

0.28

1.8

—

(3027944) Amphetamines [Presence] in Urine

129

0.77

0.28

6.7

1.2

—

(3042631) Mycobacterium sp identified in Specimen

565

1.10

0.28

2.5

2.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.27

0.27

1.4

1.9

ug/l

1.0

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

162

1709

0.95

0.27

1.6

1.8

g/l

1.3

1.5

0.32

144

1517

(1616796) Gas panel - Central venous blood

922

1.08

0.27

2.6

3.7

—

(4306422)

269

0.85

0.27

1.4

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

632

6163

1.03

0.27

2.4

2.6

mmol/l

0.8

2.25

569

5595

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

117

0.77

0.27

1.0

1.2

—

68.1

—

(3002256) Pathology report gross observation

429

4423

0.97

0.27

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

885

1.07

0.26

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

142

1501

0.94

0.26

2.3

2.4

g/l

1.4

1.1

0.43

118

1239

(3024354) Oxygen [Partial pressure] in Venous blood

353

3412

1.04

0.26

3.3

2.9

kpa

4.4

0.10

339

3294

(3035637) Corticotropin [Mass/volume] in Plasma

338

1.13

0.26

1.2

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

206

1.17

0.26

1.6

2.0

u/field

11.4

2.3

0.81

139

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.28

0.26

1.0

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.28

0.26

1.5

2.3

187.4

187.0

0.00

(3023199) Leukocytes [#/volume] in Pleural fluid

624

0.91

0.26

1.4

1.5

e6/l

11395.5

1717.5

0.46

445

(3042111) Morphology [Interpretation] in Bone marrow Narrative

707

0.92

0.26

1.5

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

337

3486

0.96

0.26

1.8

2.0

g/l

0.2

0.93

304

3197

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

113

1061

1.07

0.26

1.5

1.6

—

(40758558) Short blood count panel - Blood

871

8540

1.02

0.26

5.8

6.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

160

0.81

0.26

1.1

—

(3045788) Cell count panel - Pleural fluid

477

0.90

0.25

1.5

—

(3014271) Vancomycin [Susceptibility]

359

1.12

0.24

4.1

3.2

—

(3047189) Immunofixation for 24 hour Urine

180

0.83

0.24

2.1

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.72

0.24

1.0

1.2

—

21.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

293

1.13

0.24

1.2

mmol/l

7.8

8.1

0.23

188

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

147

0.82

0.23

1.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

147

0.82

0.23

1.3

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

338

0.89

0.23

1.5

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.32

0.23

1.0

—

(3017704) Immunofixation for Urine

243

0.86

0.23

1.1

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

106

999

1.06

0.23

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

125

0.80

0.23

1.9

2.1

umol/l

42.2

54.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

1.17

0.22

2.2

2.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

421

0.90

0.22

2.3

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

274

0.88

0.22

1.9

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

824

0.93

0.22

1.9

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

295

1.12

0.22

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

121

1147

1.06

0.22

2.8

2.9

—

(3010421) pH of Blood

111

1050

1.06

0.21

3.4

4.2

7.4

0.39

885

(3016879) Cocaine [Presence] in Urine

124

0.81

0.21

6.5

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

262

2532

1.04

0.21

3.4

3.6

mmol/l

1.5

2.1

1.32

185

1866

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

229

1.14

0.21

1.5

u/l

6.7

7.8

0.16

105

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

1.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.21

0.0

2.4

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.9

—

23.9

—

(40768793) Breast Pathology biopsy report

788

1.07

0.21

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.5

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.21

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

102

0.78

0.21

7.9

1.2

—

(3000012) Reticulocyte production index

239

1.13

0.21

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.16

0.21

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

211

2033

1.04

0.20

2.4

0.7

0.18

201

1954

(44816559) Phosphatidylethanol [Mass/volume] in Blood

335

1.11

0.20

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

480

0.92

0.20

1.3

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.20

0.0

2.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.25

0.20

1.3

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

530

5186

1.02

0.20

4.9

5.7

mmol/l

104.4

104.2

0.60

513

5049

(3037121) Protein [Mass/volume] in Urine

150

1435

1.05

0.20

2.9

2.7

g/l

0.4

0.3

0.60

520

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

217

2248

0.96

0.20

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

334

0.90

0.20

1.5

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

136

1.18

0.20

1.4

1.1

nmol/l

146.8

134.6

0.50

136

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

490

1.08

0.19

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

155

1.16

0.19

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

809

0.94

0.19

1.3

1.2

—

(44806420)

174

1.15

0.19

2.6

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

140

1339

1.05

0.19

1.2

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.22

0.19

1.0

u/ml

0.3

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

1782

1.04

0.19

2.2

2.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

213

1.13

0.18

1.3

2.0

umol/l

14.0

25.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

170

1636

1.04

0.18

2.3

2.4

g/l

2.9

3.2

2.46

124

1241

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.21

0.18

1.3

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

1686

1.04

0.18

2.2

2.3

g/l

10.1

10.3

0.21

136

1368

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

449

4393

1.02

0.18

1.3

1.2

u/ml

19.4

15.5

0.36

161

1448

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

100

1.20

0.18

1.1

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

1786

1.04

0.17

2.2

2.3

g/l

7.1

7.6

2.77

127

1265

(42529406) Shigella sp [Presence] in Stool by Culture

105

1001

1.05

0.17

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

247

0.89

0.17

1.2

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

118

1129

1.05

0.17

2.4

3.1

mmol/l

24.7

25.2

0.47

110

968

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

134

1395

0.96

0.17

2.4

2.2

g/l

37.6

36.9

0.75

107

1132

(3016018) Differential panel - Cerebral spinal fluid

257

0.89

0.17

1.7

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

186

1.13

0.16

1.3

1.1

u/l

14.4

34.2

2.03

136

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

186

1.13

0.16

1.3

1.1

u/l

76.6

90.3

0.62

139

(3028271) Lactate [Moles/volume] in Capillary blood

670

1.06

0.16

2.1

1.9

mmol/l

1.6

1.7

0.78

652

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1779

1.04

0.16

2.2

2.3

g/l

3.9

3.7

0.34

121

1215

(3000093) Morphology [Interpretation] in Blood Narrative

412

0.92

0.16

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.13

0.16

1.4

1.5

ug/l

8.1

9.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.11

0.16

4.3

7.4

14.0

13.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

193

0.88

0.15

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.76

0.15

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.76

0.15

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.75

0.15

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.75

0.15

1.2

1.1

—

12.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

197

1.12

0.15

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

161

0.87

0.15

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

213

0.89

0.15

1.2

u/l

43.6

23.9

0.65

173

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

150

0.87

0.14

1.3

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.79

0.14

1.3

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

909

1.05

0.14

3.5

4.4

kpa

5.0

0.06

883

(3021447) Carbon dioxide [Partial pressure] in Venous blood

420

4124

1.02

0.14

3.4

3.3

kpa

5.8

0.58

405

3997

(3051387) C reactive protein [Mass/volume] in Capillary blood

911

1.04

0.13

3.6

4.0

mg/l

37.1

29.6

0.92

593

(3009343) pH of Capillary blood

268

2619

1.02

0.13

3.4

3.7

7.4

0.12

312

(46235355) HIV 1 and 2 tests - Meaningful Use set

241

2468

0.97

0.13

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

325

0.92

0.13

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

151

1.13

0.13

1.8

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

520

0.94

0.13

5.0

5.9

mg/l

12.5

12.8

0.14

466

(3044640) Blood type and Crossmatch panel - Blood

1177

11662

1.01

0.13

2.3

2.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

211

0.90

0.13

2.1

3.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

113

1.15

0.13

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

110

0.82

0.13

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

413

1.07

0.12

3.4

3.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

687

1.05

0.12

1.4

1.5

g/l

29.7

30.3

0.17

606

(3027315) Oxygen [Partial pressure] in Blood

913

1.04

0.12

3.5

4.4

kpa

8.5

8.3

0.78

886

(3016650) Hepatitis A virus Ab [Presence] in Serum

355

0.93

0.12

1.1

—

(4024509)

453

1.06

0.12

1.6

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

649

1.05

0.12

1.2

u/l

32.7

49.1

0.97

560

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

125

1290

0.97

0.12

2.4

2.3

g/l

0.0

0.42

112

1149

(3045142) Bone marrow Pathology biopsy report

415

0.94

0.11

1.2

—

(3017569) Oxygen content in Arterial blood

230

1.09

0.11

2.0

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

201

1.09

0.11

2.0

—

(3023410) Appearance of Cerebral spinal fluid

240

0.92

0.11

1.7

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

363

0.94

0.11

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

163

1.10

0.10

1.5

1.4

2.6

2.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

426

1.06

0.10

1.3

1.2

—

(3035880) pH of Pleural fluid

270

1.07

0.10

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

358

1.06

0.10

1.1

1.3

e6/l

24837.1

169545.5

2.61

237

(3004775) Volume in Urine collected for unspecified duration

319

1.07

0.10

1.9

2.2

748.0

637.4

0.25

191

(3012501) Base excess in Blood by calculation

909

1.03

0.10

3.4

4.4

mmol/l

2.6

2.8

0.35

629

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

183

1.09

0.10

1.6

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

261

1.07

0.10

1.1

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

269

0.93

0.10

2.7

2.4

—

(3028433) Virus identified in Specimen by Culture

106

1.13

0.09

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.09

0.09

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

116

1.12

0.09

1.8

1.7

nmol/l

1.7

10.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

268

0.93

0.09

1.2

1.1

—

(3002032) Base excess in Venous blood by calculation

417

4117

1.01

0.09

3.4

3.3

mmol/l

1.7

2.0

0.93

322

3316

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

319

0.94

0.09

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

319

0.94

0.09

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

319

0.94

0.09

1.3

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

270

2656

1.02

0.09

3.4

3.7

kpa

5.2

0.09

249

2396

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

237

0.93

0.09

1.0

ng/l

376.7

311.5

0.40

147

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

479

4843

0.99

0.08

3.2

3.7

u/l

249.5

249.2

0.02

441

4487

(44790047)

359

0.95

0.08

1.3

1.4

—

(44790049)

359

0.95

0.08

1.3

1.4

—

(44806118)

359

0.95

0.08

1.3

1.4

—

(44790048)

359

0.95

0.08

1.3

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

107

1.12

0.08

1.8

2.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

156

1527

1.02

0.08

3.0

2.8

mg/l

32.0

62.7

2.47

131

1265

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.79

0.08

1.0

1.1

116.8

95.1

—

(3034426) Prothrombin time (PT)

0.78

0.08

1.0

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

152

1488

1.02

0.08

3.0

2.8

ratio

2.1

3.3

0.43

110

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

123

0.89

0.08

1.3

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

0.80

0.07

1.2

1.5

g/l

37.3

27.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.80

0.07

1.2

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

692

0.97

0.07

3.1

3.9

1.5

0.07

517

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

189

1922

0.98

0.07

1.5

1.6

1.98

157

1571

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

823

0.97

0.07

2.5

2.9

u/ml

193.0

879.0

1.19

743

(3000492) Spirometry study

226

2294

0.98

0.07

1.4

1.6

—

(3000285) Sodium [Moles/volume] in Blood

0.87

0.07

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.82

0.07

1.3

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

157

1.08

0.07

1.1

1.5

u/l

4.7

7.1

1.13

128

(3011288) Drugs identified in Urine by Screen method

1.05

0.07

13.3

1.5

—

(4027681)

0.86

0.06

1.3

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

103

0.87

0.06

1.3

1.9

ug/l

17.2

384.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

227

1.06

0.05

3.7

3.8

—

(3020491) Glucose [Moles/volume] in Blood

243

0.95

0.05

1.1

2.7

mmol/l

7.0

7.1

0.09

167

(3021901) Oxygen saturation in Capillary blood

851

1.02

0.05

2.4

2.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

534

1.03

0.05

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

356

1.04

0.05

1.0

1.1

iu/ml

15.2

82.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

100

1.10

0.05

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

222

0.95

0.05

1.1

1.2

u/l

114.3

86.0

0.33

187

(3044242) Glucose [Moles/volume] in Arterial blood

252

0.95

0.05

2.0

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

575

0.97

0.04

1.5

1.3

e6/l

713.7

684.1

0.03

477

(3017143) Hepatitis C virus Ab [Presence] in Serum

215

2173

0.99

0.04

1.4

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

574

0.98

0.04

1.5

1.3

e6/l

17.6

27.5

0.23

451

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

427

1.03

0.04

1.3

1.2

—

21.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

149

1508

0.99

0.04

1.3

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

156

1578

0.99

0.04

4.2

4.1

mmol/l

24.3

24.9

1.41

141

1391

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

670

6727

1.00

0.03

3.0

e6/l

1.2

1.4

0.41

432

3866

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

111

1125

0.99

0.03

1.4

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

141

1.06

0.03

1.1

—

(3008295) Osmolality of Serum or Plasma

379

1.03

0.03

1.3

mosm/kgh2o

272.3

275.0

0.47

257

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.09

0.03

1.9

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

501

0.98

0.03

1.3

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

469

1.02

0.03

3.3

3.2

—

(3032057) Clostridioides difficile [Presence] in Stool

112

1.07

0.03

1.5

1.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

132

1.06

0.02

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

132

1.06

0.02

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

142

1.06

0.02

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

500

0.98

0.02

1.3

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

281

1.03

0.02

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

158

0.95

0.02

2.1

2.6

37.3

37.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

379

0.98

0.02

1.2

u/l

41.0

60.1

3.68

249

(40768800) Prostate Pathology biopsy report

700

0.99

0.02

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

238

0.97

0.02

1.0

ng/l

798.2

649.7

0.58

143

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

278

0.97

0.02

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

980

1.01

0.01

1.4

1.5

—

(3016228) CD19 cells/100 cells in Blood

113

1.06

0.01

1.8

1.9

4.9

7.8

0.91

107

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

147

0.95

0.01

1.3

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

143

1.05

0.01

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

884

8854

1.00

0.01

2.2

2.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

492

1.02

0.01

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

502

1.02

0.01

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

522

1.02

0.01

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

193

1.04

0.01

1.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

193

1.04

0.01

1.4

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

193

1.04

0.01

1.4

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

193

1.04

0.01

1.4

1.5

—

(3016750) Collection duration of Urine

217

0.97

0.01

1.7

1.9

min

488.7

494.3

0.12

147

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

237

0.97

0.01

1.0

ng/l

39.1

43.6

0.34

146

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

223

1.03

0.01

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

257

0.97

0.01

1.2

1.1

122.9

116.7

0.49

225

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

367

0.98

0.01

1.1

1.2

u/ml

126.8

113.9

0.53

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

631

6320

1.00

0.01

3.2

e6/l

2.5

2.9

0.57

398

3500

(3034860) Kappa light chains.free [Mass/volume] in Serum

154

1532

1.01

0.01

3.0

2.8

mg/l

45.2

95.8

0.78

128

1269

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

967

0.99

0.01

1.5

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

693

1.01

0.01

1.5

2.0

umol/l

31.6

31.9

0.02

555

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

286

0.98

0.00

1.5

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

224

1.03

0.00

1.3

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

336

0.98

0.00

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

546

0.99

0.00

2.2

1.9

89.9

89.0

0.73

539

(3005719) IgG [Mass/volume] in Serum or Plasma

215

2143

1.00

0.00

2.2

2.7

g/l

10.3

10.6

0.53

194

1928

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

964

1.01

0.00

1.2

1.4

—

14.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

117

1164

1.01

0.00

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

175

1.03

0.00

1.1

iu/ml

—

3.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

311

1.00

0.00

1.6

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

325

1.02

0.00

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

496

1.01

0.00

1.3

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

526

1.01

0.00

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

321

1.00

0.00

1.1

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

141

0.99

0.00

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

225

1.02

0.00

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.00

0.00

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.00

0.00

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

180

1.00

0.00

1.1

u/ml

0.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.00

0.00

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

163

1628

1.00

0.00

3.4

4.1

u/ml

63.6

89.6

0.41

154

1554

(3051101) Glucose [Moles/volume] in Cord blood

1.05

0.00

5.4

5.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

447

1.01

0.00

1.4

mmol/l

5.8

6.6

1.15

412

(4015189)

119

1.01

0.00

2.6

2.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

257

1.01

0.00

1.2

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

837

1.00

0.00

1.4

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

155

1.03

0.00

1.3

3.6

mg/l

64.7

62.5

—

102

(3005988) Vibrio sp identified in Specimen by Organism specific culture

502

1.00

0.00

1.3

1.4

—

(3036603) Volume of Urine

205

0.98

0.00

1.9

1.5

1783.0

1768.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

179

1.01

0.00

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

179

1.01

0.00

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

179

1.01

0.00

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

539

1.00

0.00

2.4

1.3

nmol/l

0.8

0.12

429

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

332

0.99

0.00

1.5

1.4

29.3

27.4

0.10

214

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

395

0.99

0.00

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

167

1.02

0.00

1.3

1.2

mmol/l

10.4

11.8

—

(3025130) Human papilloma virus identified in Specimen

193

0.98

0.00

2.0

1.6

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.2

—

628.5

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.87

0.00

1.5

2.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

4.8

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

74.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.85

0.00

1.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.98

0.00

1.2

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

0.85

0.00

47.0

28.3

ug/l

6.6

7.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.95

0.00

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.95

0.00

1.3

g/l

0.4

0.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.92

0.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.92

0.00

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.89

0.00

2.6

1.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.89

0.00

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.88

0.00

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

10.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.92

0.00

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.92

0.00

1.1

—

(40768446) Kidney Pathology biopsy report

0.89

0.00

1.9

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.94

0.00

1.5

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_GLAUCOMA_XFG and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_GLAUCOMA_XFG	0.876 [0.82, 0.94]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.178

During the follow-up period (1.1.1998 — 31.12.2019), 9065 out of 22936 females with H7_GLAUCOMA_XFG died.

Males

Parameter	HR [95% CI]	p-value
H7_GLAUCOMA_XFG	0.91 [0.84, 0.99]	0.032
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 4878 out of 11833 males with H7_GLAUCOMA_XFG died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCOMA_XFG.

N-year risk	Females	Males
1	0.071%	0.185%
5	0.498%	0.955%
10	1.294%	2.41%
15	2.583%	4.733%
20	4.311%	7.942%

Relationships between endpoints

↥

Index endpoint: H7_GLAUCOMA_XFG – Glaucoma, exfoliation

GWS hits: 20

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Glaucoma, exfoliation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints